Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STAR COMBO PHARMA LIMITED Major Shareholding Notification 2020

Jun 1, 2020

65746_rns_2020-06-01_6e754da2-6544-48df-bfdf-a20068aa8b2b.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Form604

Corporations Act 2001 Section 671B

Notice of change of interests of substantial holder

To CompanyName/Scheme ACN/ARSN Star Combo Pharma Limited
ABN: 38 615 728 375
1. Details of substantial holder (1)
Name: Su Zhang
ACN/ARSN (if applicable):
There was a change in the interests of the
substantial holder on:
26 May 2020
The previous notice was given to the company on: 23 Aug 2018
The previous notice was dated: 23 Aug 2018
2 Previous and present voting power

The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate(2) had a relevant interest (3) in when last required, and when now required, to give a substantial holding notice to the company or scheme, are as follows:

Class of securities (4)
Fully Paid Ordinary Shares
Previous notice Present notice
Person's votes
11,448,980
Voting power (5)
14.39%
Person's votes
11,448,980
Voting power (5)
8.44%

3. Changes in relevant interests

Particulars of each change in, or change in the nature of, a relevant interest of the substantial holder or an associate in voting securities of the company or scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows:

Date of
change
Person whose
relevant interest
changed
Nature of
Change (6)
Consideration
Given in relation
to change $(7)$
Class and
number of
securities
affected
Person's votes
affected
26 May 2020 Goldenstar Pharmaceutical
Investment Limited
Private Placement
49million shares
\$33,320,000 49million Ordinary
Shares
36.13%

4 Present relevant interests

Particulars of each relevant interest of the substantial holder in voting securities after the change are as follows:

Holder of
relevant interest
Registered holder
of securities
Person entitled
to be registered
as holder (8)
Nature of relevant
interest (6)
Class and number
of securities
Person's votes
Su Zhang Su Zhang Su Zhang Direct Holding 11,448,980 8.44%

5 Changes in association

The persons who have become associates (2) of, ceased to be associates of, or have changed the nature of their association (9) with, the substantial holder in relation to voting interests in the company or scheme are as follows:

Name and ACN/ARSN (if applicable) Nature of association
N/A

6 Addresses

Si

The addresses of persons named in this form are as follows:

Name Address
12 Burbang Crescent, Rydalmere, NSW, 2116
Su Zhang
gnature
Print name:
Su Zhang capacity
Sign here: date 29 May 2020
DIRECTIONS
clearly set out in paragraph 6 of the form. If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee
of an equity trust), the names could be induded in an annexue to the form. If the relevart interests of a group of persons are essentially similar, they
may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is
2 See the definition of "associate" in section9 of the Corporations Act 2001.
3 See the definition of "relevant interest" in sections608and671B(7)of the Corporations Act2001.
4 The voting shares of a company constitute one class unless divided into separate classes.
5 The person's votes divided by the total votes in the body corporate or scheme multiplied by 100.
  • 6 Include details of:
  • a. Any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B (4)applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, schemeor arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement, and
  • b. Any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).
  • C. See the definition of "relevant agreement" in section9 of the Corporations Act 2001.
  • Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, 7 become entitled to receive in relation to that acquisition. Details must be induded even if the benefit is condtional on the happening or not of a cortingency Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.

If the substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write "unknown". $\boldsymbol{8}$

Give details, if appropriate, of the present association and any change in that association since the last substantial holding notice. 9